Abstract
We describe a 38-year-old male who underwent percutaneous coronary intervention (PCI) using a third-generation drug-eluting stent (DES) with a thin stent for an anomalous left main coronary artery (LMCA) originating from the right coronary sinus with a retro-aortic course. Six months later, in-stent restenosis (ISR) occurred due to stent implantation in angled lesions with significant hinge motion. An intravascular ultrasound (IVUS) revealed significant neointimal hyperplasia. The vessel wall of an angled coronary artery lesion is exposed to mechanical stress from the deployed stent. It has been reported before in the major coronary arteries but not in an anomalous LMCA.
Keywords: restenosis, angioplasty, balloon, coronary, drug-eluting stent
Introduction
An angled coronary lesion, which is often accompanied by hinge motion, is reportedly a risk factor for in-stent restenosis (ISR) with all generations of coronary stents [1]. Several mechanisms are behind the higher incidence of ISR in angled lesions [2]. Initially, it was described after bare-metal stent (BMS) implantation. Drug-eluting stents (DES) have dramatically reduced the rate of ISR as compared with BMS. However, ISR in angled lesions remains a problem, especially with old-generation DES having a closed-cell, stainless-steel design, which has low conformability and flexibility. Recently, third-generation DES, which have thin stent struts and an open-cell design, lead to better conformability and flexibility at the expense of weak radial strength and the risk of stent fracture, especially at an angled lesion. Several studies have reported the relationship between angled lesions with hinge motion and ISR after DES implantation [3]. We describe a case of ISR due to an acute angle lesion with hinge motion after third-generation DES implantation for the first time in an anomalous LMCA.
Case presentation
A 38-year-old male patient with a 15-pack per year smoking history presented to another hospital with acute anterolateral ST-elevation myocardial infarction. He was thrombolyzed with t-PA with the complete resolution of his electrocardiography (ECG) changes. Echocardiogram revealed mild left ventricular (LV) dysfunction with a left ventricular ejection fraction (LVEF) of 40%-45% and anterior/lateral wall hypokinesis. He was then transferred to our center where he was taken to the catheterization laboratory and a diagnostic coronary angiogram was done after obtaining informed consent. The angiogram revealed a normal right coronary artery and an anomalous origin of the left main coronary artery from the right coronary cusp (Figure 1). The anomalous left main showed a mid-shaft hazy and eccentric lesion (Figure 2). Normal left anterior descending and normal left circumflex were present. The patient was discussed in a heart team meeting and it was decided to proceed with a coronary CT angiogram to define the course of the anomalous LMCA, which was retro-aortic. The patient's informed decision was to opt for percutaneous coronary intervention (PCI). A percutaneous intervention was carried out using a right Judkins 4 guiding catheter and a balance middle weight (BMW) wire that passed to the distal left anterior descending artery (LAD) and a direct 4.0x22 mm resolute stent deployed (Figure 3). A second 4.0x8 mm resolute stent was deployed proximally to cover an area of plaque shift. This was followed by post-stent balloon dilatation using a 4.5X15 mm non-complaint balloon at high pressure. A final intravascular ultrasound (IVUS) was done, which revealed good stent apposition (Figure 4). The patient discharged home within 48 hours [4].
Figure 1. Coronary angiography showing right and left coronary arteries originating from the right coronary sinus of Valsalva.
Figure 2. Coronary angiography showing right and left coronary arteries originating from the right coronary sinus of Valsalva.
Figure 3. Post stenting of the anomalous left main.
Figure 4. The final intravascular ultrasound image of the stented segment with excellent apposition.
Six months later, he was admitted again due to the recurrence of chest pain with a normal ECG and mild troponin rise. The echocardiogram revealed an LVEF of 50%. Of note, the patient quit smoking since discharge. The coronary angiogram revealed significant proliferative type three ISR (10 mm extending beyond the stent margins) (Figure 5). IVUS was done and revealed intimal hyperplasia with no evidence of an obvious stent fracture or malapposition. The patient was offered surgery but he refused. In view of the diffuse pattern of intimal hyperplasia and no stent/native artery size mismatch, we proceeded with the placement of the 4x15 mm Xience stent (Abbott Laboratories, Lake Bluff, Illinois), followed by 4.5x12 mm non-complaint balloon dilation at high pressure (Figure 6). The final IVUS revealed an excellent result.
Figure 5. Type three left main in-stent restenosis.
Figure 6. Post in-stent restenosis stenting.
Discussion
The clinical incidence of ISR after BMS implantation is approximately 20%-35%. The use of DES has led to a further decrease in the occurrence of ISR to 5%-10% [5]. ISR after coronary angioplasty is currently one of the main limitations of this method, leading to the recurrence of exertional angina pectoris or acute coronary syndromes. Several risk factors contributed to the development of ISR [6]. These include patients, lesions, and procedural factors (Table 1). Angled lesions had a higher incidence rate of ISA over non-angled lesions and were an independent predictor for ISA in several reports. There are several hypotheses behind ISR in angled lesions [6]. First is the mechanical stress (shearing force) from the stent strut to the vessel wall of angled lesions that provokes neointimal hyperplasia. Second, some struts in the inner curvature at the edge would not be well attached to the vessel wall in angled lesions even if the stent was well expanded with recommended balloon pressure. Third, stent recoil was observed in some stent designs. A recent report indicated that stent recoil after the first-generation DES occurred in 0%-2%. Some speculate that stent recoil is prone to occur in hinge motion lesions because excessive vessel movement causes stent compression at the hinge point during the cardiac cycle, and stent recoil causes a decrease in minimal stent area. Fourth, a stent fracture had been reported as the reason for ISR in angled lesions in several studies. Furthermore, small stent fractures, such as a single strut fracture, which is difficult to detect with fluoroscopy or IVUS, might occur at the angled lesions. In one study, they found that the angle of ≥16° is the optimal cut-off value for predicting ISR [2].
Table 1. In-stent restenosis risk factors.
PCI: percutaneous coronary intervention; MLD: minimal lumen diameter
| Risk Factors |
| Patient Factors |
| Age |
| Female sex |
| Genetic factors |
| Diabetes mellitus |
| Renal insufficiency |
| Acute coronary syndrome |
| Lesion Factors |
| Long lesions |
| Small vessels |
| Complex B2/C lesions |
| Chronic closures |
| Ostial lesions |
| Bifurcation lesions |
| Lesions in venous bypass |
| Recurrent restenosis |
| Multivessel coronary artery disease |
| Angled lesions |
| Procedure Factors |
| Type of stent |
| Number of stents and total length |
| Stent overlap |
| Stent underexpansion |
| Stent fractures |
| Post-PCI MLD |
The clinical significance of the high incidence of vessel wall injuries and ISA in angled lesions is still unclear. A recent clinical study of second-generation DES reported that lesion angle had no impact on one-year clinical outcomes, inconsistent with a past report in the bare metal stent era [7]. This might be derived from the better mechanical performance of second-generation DES with thinner struts and improved cell design. Some reports have demonstrated that injuries of larger size and ISA would not have healed well, resulting in incomplete healing of vessel injuries and persistent strut malapposition [8]. Therefore, we need further studies to evaluate the long-term clinical outcomes and clinical significance of optical coherence tomography (OCT) findings in patients with angled lesions.
Conclusions
ISR is not uncommon and several risk factors have been reported as predisposing factors for such unwanted outcomes. Stenting of an angled lesion is associated with a higher incidence of ISR as compared to a non-angled lesion. It has been reported previously in the major coronary arteries. To our knowledge, our case is the first to report such an effect on an anomalous left main coronary artery.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained by all participants in this study
References
- 1.Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. Buccheri D, Piraino D, Andolina G, Cortese B. J Thorac Dis. 2016;8:1150. doi: 10.21037/jtd.2016.10.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Impact of hinge motion on in-stent restenosis after sirolimus-eluting stent implantation [EPub] Ino Y, Kubo T, Kitabata H, et al. https://www.ncbi.nlm.nih.gov/pubmed/21628832. Circ J. 2011;75:1878–1884. doi: 10.1253/circj.cj-10-1182. [DOI] [PubMed] [Google Scholar]
- 3.Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Colombo A, Orlic D, Stankovic G, et al. Circulation. 2003;6:2178–2180. doi: 10.1161/01.CIR.0000070592.04766.36. [DOI] [PubMed] [Google Scholar]
- 4.Coronary intervention of an anomalous left main coronary artery arising from the right sinus of Valsalva presented as acute coronary syndrome. Al Bugami S, Althobaiti MW, Alrahemi J, Alsaiedi AJ, Kashkari WA. JCCR. 2016;5:1–3. [Google Scholar]
- 5.Current management of in-stent restenosis. Her AY, Shin ES. Korean Circ J. 2018;48:337–349. doi: 10.4070/kcj.2018.0103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Treatment of coronary in-stent restenosis: a systematic review. Pleva L, Kukla P, Hlinomaz O. J Geriatr Cardiol. 2018;15:173–184. doi: 10.11909/j.issn.1671-5411.2018.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Risk of target lesion failure in relationship to vessel angiographic geometry and stent conformability using the second generation of drug-eluting stents. Gomez-Lara J, Heo JH, Brugaletta S, et al. Am Heart J. 2011;162:1062–1079. doi: 10.1016/j.ahj.2011.09.010. [DOI] [PubMed] [Google Scholar]
- 8.Vascular tissue reaction to acute malapposition in human coronary arteries. Sequential assessment with optical coherence tomography. Gutierrez-Chico JL, Wykrzykowska J, Nuesch E, et al. Circ Cardiovasc Interv. 2012;5:20–29. doi: 10.1161/CIRCINTERVENTIONS.111.965301. [DOI] [PubMed] [Google Scholar]






